Does the LENT score risk‐stratify patients with malignant pleural mesothelioma? An observational study

BACKGROUND: Malignant pleural mesothelioma (MPM) is a rare, highly aggressive and deadly disease with a poor patient life expectancy. A few years ago, the main challenge was the histological diagnosis of this disease; at present, the search for the best therapeutic strategy is now a priority. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chollet, Bertrand, Guinde, Julien, Laroumagne, Sophie, Dutau, Hervé, Astoul, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169304/
https://www.ncbi.nlm.nih.gov/pubmed/33949775
http://dx.doi.org/10.1111/1759-7714.13987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169304/
https://www.ncbi.nlm.nih.gov/pubmed/33949775
http://dx.doi.org/10.1111/1759-7714.13987

Ejemplares similares